Quantitative Structure–Activity Relationships for Human Galectin-3 Inhibitors: Insights from Quantum Chemical Interaction Energy Terms Article Swipe
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1021/acs.jcim.5c00592
Human galectin-3 (hGal-3) is a target protein implicated in various diseases, including fibrosis, and several inhibitors have been identified. In this study, we investigated the quantitative structure-activity relationships (QSAR) that influence hGal-3 binding affinity of 21 inhibitors using four quantum chemical interaction energy terms: electrostatic (ES), charge transfer (CT+mix), exchange (EX), and dispersion interactions (DI). These terms were derived from high-precision fragment molecular orbital (FMO) calculations. Our analysis revealed that the binding affinity could be explained primarily by the CT+mix and DI terms. We further decomposed these terms to analyze the contributions of specific hGal-3 residues and evaluated the correlations between residue contributions and binding affinity. For CT+mix, key interactions with R144, N160, E184, and R186 were identified, while for DI, interactions with R144 and R186 were the most significant. In the case of CT+mix, we found that charge transfer from E184 to the inhibitor stabilized the CT+mix interaction energy, contributing to the binding affinity. DI analysis revealed that parallel stacking between the aromatic ring of the inhibitor and the guanidine moieties of R144 and R186, as well as CH-π interactions with R186, stabilized the DI-induced interaction energy. Based on these findings, we propose a design guideline for high affinity hGal-3 inhibitors: lowering the energy of the unoccupied orbitals in the inhibitor to facilitate charge transfer from E184 and introducing substituents near R144 and R184 to enhance shape complementarity and stabilize dispersion interactions. The FMO-based QSAR approach allows for investigation of the correlation between quantum chemical interactions and binding affinity, offering a new perspective for molecular design.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1021/acs.jcim.5c00592
- OA Status
- green
- Cited By
- 1
- References
- 34
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411187298
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411187298Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1021/acs.jcim.5c00592Digital Object Identifier
- Title
-
Quantitative Structure–Activity Relationships for Human Galectin-3 Inhibitors: Insights from Quantum Chemical Interaction Energy TermsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-06-10Full publication date if available
- Authors
-
Tomohide Masuda, Chiduru Watanabe, Koichiro Kato, Teruki Honma, Masateru Ohta, Mitsunori IkeguchiList of authors in order
- Landing page
-
https://doi.org/10.1021/acs.jcim.5c00592Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://www.ncbi.nlm.nih.gov/pmc/articles/12199291Direct OA link when available
- Concepts
-
Quantum chemical, Chemistry, Interaction energy, Protein–protein interaction, Computational biology, Computational chemistry, Biochemistry, Molecule, Biology, Organic chemistryTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
34Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411187298 |
|---|---|
| doi | https://doi.org/10.1021/acs.jcim.5c00592 |
| ids.doi | https://doi.org/10.1021/acs.jcim.5c00592 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40491356 |
| ids.openalex | https://openalex.org/W4411187298 |
| fwci | 2.59086319 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D021281 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Quantitative Structure-Activity Relationship |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D011789 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Quantum Theory |
| mesh[3].qualifier_ui | Q000037 |
| mesh[3].descriptor_ui | D037502 |
| mesh[3].is_major_topic | True |
| mesh[3].qualifier_name | antagonists & inhibitors |
| mesh[3].descriptor_name | Galectin 3 |
| mesh[4].qualifier_ui | Q000737 |
| mesh[4].descriptor_ui | D037502 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | chemistry |
| mesh[4].descriptor_name | Galectin 3 |
| mesh[5].qualifier_ui | Q000378 |
| mesh[5].descriptor_ui | D037502 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | metabolism |
| mesh[5].descriptor_name | Galectin 3 |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D011485 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Protein Binding |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D001798 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Blood Proteins |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D013816 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Thermodynamics |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008958 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Models, Molecular |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D037161 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Galectins |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D021281 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Quantitative Structure-Activity Relationship |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D011789 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Quantum Theory |
| mesh[14].qualifier_ui | Q000037 |
| mesh[14].descriptor_ui | D037502 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | antagonists & inhibitors |
| mesh[14].descriptor_name | Galectin 3 |
| mesh[15].qualifier_ui | Q000737 |
| mesh[15].descriptor_ui | D037502 |
| mesh[15].is_major_topic | True |
| mesh[15].qualifier_name | chemistry |
| mesh[15].descriptor_name | Galectin 3 |
| mesh[16].qualifier_ui | Q000378 |
| mesh[16].descriptor_ui | D037502 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | metabolism |
| mesh[16].descriptor_name | Galectin 3 |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D011485 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Protein Binding |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D001798 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Blood Proteins |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D013816 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Thermodynamics |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D008958 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Models, Molecular |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D037161 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Galectins |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D021281 |
| mesh[22].is_major_topic | True |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Quantitative Structure-Activity Relationship |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D006801 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Humans |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D011789 |
| mesh[24].is_major_topic | True |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Quantum Theory |
| mesh[25].qualifier_ui | Q000037 |
| mesh[25].descriptor_ui | D037502 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | antagonists & inhibitors |
| mesh[25].descriptor_name | Galectin 3 |
| mesh[26].qualifier_ui | Q000737 |
| mesh[26].descriptor_ui | D037502 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | chemistry |
| mesh[26].descriptor_name | Galectin 3 |
| mesh[27].qualifier_ui | Q000378 |
| mesh[27].descriptor_ui | D037502 |
| mesh[27].is_major_topic | True |
| mesh[27].qualifier_name | metabolism |
| mesh[27].descriptor_name | Galectin 3 |
| mesh[28].qualifier_ui | |
| mesh[28].descriptor_ui | D011485 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | |
| mesh[28].descriptor_name | Protein Binding |
| mesh[29].qualifier_ui | |
| mesh[29].descriptor_ui | D001798 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | |
| mesh[29].descriptor_name | Blood Proteins |
| mesh[30].qualifier_ui | |
| mesh[30].descriptor_ui | D013816 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | |
| mesh[30].descriptor_name | Thermodynamics |
| mesh[31].qualifier_ui | |
| mesh[31].descriptor_ui | D008958 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | |
| mesh[31].descriptor_name | Models, Molecular |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D037161 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Galectins |
| type | article |
| title | Quantitative Structure–Activity Relationships for Human Galectin-3 Inhibitors: Insights from Quantum Chemical Interaction Energy Terms |
| awards[0].id | https://openalex.org/G6316823752 |
| awards[0].funder_id | https://openalex.org/F4320311405 |
| awards[0].funder_award_id | JP23fk0310517 |
| awards[0].funder_display_name | Japan Agency for Medical Research and Development |
| awards[1].id | https://openalex.org/G4874870031 |
| awards[1].funder_id | https://openalex.org/F4320311405 |
| awards[1].funder_award_id | JP23ama121030 |
| awards[1].funder_display_name | Japan Agency for Medical Research and Development |
| awards[2].id | https://openalex.org/G7412970795 |
| awards[2].funder_id | https://openalex.org/F4320311405 |
| awards[2].funder_award_id | JP23ama121023 |
| awards[2].funder_display_name | Japan Agency for Medical Research and Development |
| biblio.issue | 12 |
| biblio.volume | 65 |
| biblio.last_page | 6297 |
| biblio.first_page | 6287 |
| grants[0].funder | https://openalex.org/F4320311405 |
| grants[0].award_id | JP23ama121023 |
| grants[0].funder_display_name | Japan Agency for Medical Research and Development |
| grants[1].funder | https://openalex.org/F4320311405 |
| grants[1].award_id | JP23ama121030 |
| grants[1].funder_display_name | Japan Agency for Medical Research and Development |
| grants[2].funder | https://openalex.org/F4320311405 |
| grants[2].award_id | JP23fk0310517 |
| grants[2].funder_display_name | Japan Agency for Medical Research and Development |
| topics[0].id | https://openalex.org/T12387 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9998999834060669 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Galectins and Cancer Biology |
| funders[0].id | https://openalex.org/F4320311405 |
| funders[0].ror | https://ror.org/004rtk039 |
| funders[0].display_name | Japan Agency for Medical Research and Development |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2991951333 |
| concepts[0].level | 3 |
| concepts[0].score | 0.6677979230880737 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q188403 |
| concepts[0].display_name | Quantum chemical |
| concepts[1].id | https://openalex.org/C185592680 |
| concepts[1].level | 0 |
| concepts[1].score | 0.48864322900772095 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[1].display_name | Chemistry |
| concepts[2].id | https://openalex.org/C22499117 |
| concepts[2].level | 3 |
| concepts[2].score | 0.42204421758651733 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2253702 |
| concepts[2].display_name | Interaction energy |
| concepts[3].id | https://openalex.org/C11804247 |
| concepts[3].level | 2 |
| concepts[3].score | 0.41748252511024475 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q896177 |
| concepts[3].display_name | Protein–protein interaction |
| concepts[4].id | https://openalex.org/C70721500 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4044284224510193 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q177005 |
| concepts[4].display_name | Computational biology |
| concepts[5].id | https://openalex.org/C147597530 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3956631124019623 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q369472 |
| concepts[5].display_name | Computational chemistry |
| concepts[6].id | https://openalex.org/C55493867 |
| concepts[6].level | 1 |
| concepts[6].score | 0.22497400641441345 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[6].display_name | Biochemistry |
| concepts[7].id | https://openalex.org/C32909587 |
| concepts[7].level | 2 |
| concepts[7].score | 0.19915691018104553 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11369 |
| concepts[7].display_name | Molecule |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.19773975014686584 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C178790620 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0793275535106659 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q11351 |
| concepts[9].display_name | Organic chemistry |
| keywords[0].id | https://openalex.org/keywords/quantum-chemical |
| keywords[0].score | 0.6677979230880737 |
| keywords[0].display_name | Quantum chemical |
| keywords[1].id | https://openalex.org/keywords/chemistry |
| keywords[1].score | 0.48864322900772095 |
| keywords[1].display_name | Chemistry |
| keywords[2].id | https://openalex.org/keywords/interaction-energy |
| keywords[2].score | 0.42204421758651733 |
| keywords[2].display_name | Interaction energy |
| keywords[3].id | https://openalex.org/keywords/protein–protein-interaction |
| keywords[3].score | 0.41748252511024475 |
| keywords[3].display_name | Protein–protein interaction |
| keywords[4].id | https://openalex.org/keywords/computational-biology |
| keywords[4].score | 0.4044284224510193 |
| keywords[4].display_name | Computational biology |
| keywords[5].id | https://openalex.org/keywords/computational-chemistry |
| keywords[5].score | 0.3956631124019623 |
| keywords[5].display_name | Computational chemistry |
| keywords[6].id | https://openalex.org/keywords/biochemistry |
| keywords[6].score | 0.22497400641441345 |
| keywords[6].display_name | Biochemistry |
| keywords[7].id | https://openalex.org/keywords/molecule |
| keywords[7].score | 0.19915691018104553 |
| keywords[7].display_name | Molecule |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.19773975014686584 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/organic-chemistry |
| keywords[9].score | 0.0793275535106659 |
| keywords[9].display_name | Organic chemistry |
| language | en |
| locations[0].id | doi:10.1021/acs.jcim.5c00592 |
| locations[0].is_oa | False |
| locations[0].source.id | https://openalex.org/S167262187 |
| locations[0].source.issn | 1549-9596, 1549-960X |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 1549-9596 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Journal of Chemical Information and Modeling |
| locations[0].source.host_organization | https://openalex.org/P4310320006 |
| locations[0].source.host_organization_name | American Chemical Society |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320006 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Journal of Chemical Information and Modeling |
| locations[0].landing_page_url | https://doi.org/10.1021/acs.jcim.5c00592 |
| locations[1].id | pmid:40491356 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Journal of chemical information and modeling |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40491356 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:12199291 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc-nd |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc-nd |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | J Chem Inf Model |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12199291 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5109282775 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Tomohide Masuda |
| authorships[0].countries | JP |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I89630735 |
| authorships[0].affiliations[0].raw_affiliation_string | Yokohama City University |
| authorships[0].affiliations[1].raw_affiliation_string | Graduate School of Medical Life Science |
| authorships[0].institutions[0].id | https://openalex.org/I89630735 |
| authorships[0].institutions[0].ror | https://ror.org/0135d1r83 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I89630735 |
| authorships[0].institutions[0].country_code | JP |
| authorships[0].institutions[0].display_name | Yokohama City University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Tomohide Masuda |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Graduate School of Medical Life Science, Yokohama City University |
| authorships[1].author.id | https://openalex.org/A5076104735 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0742-3896 |
| authorships[1].author.display_name | Chiduru Watanabe |
| authorships[1].countries | JP |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210116810 |
| authorships[1].affiliations[0].raw_affiliation_string | RIKEN, Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[1].institutions[0].id | https://openalex.org/I4210116810 |
| authorships[1].institutions[0].ror | https://ror.org/023rffy11 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210110652, https://openalex.org/I4210116810 |
| authorships[1].institutions[0].country_code | JP |
| authorships[1].institutions[0].display_name | RIKEN Center for Biosystems Dynamics Research |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Chiduru Watanabe |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | RIKEN, Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[2].author.id | https://openalex.org/A5071683141 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-4392-8741 |
| authorships[2].author.display_name | Koichiro Kato |
| authorships[2].countries | JP |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I135598925 |
| authorships[2].affiliations[0].raw_affiliation_string | Center for Molecular Systems, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I135598925 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan |
| authorships[2].institutions[0].id | https://openalex.org/I135598925 |
| authorships[2].institutions[0].ror | https://ror.org/00p4k0j84 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I135598925 |
| authorships[2].institutions[0].country_code | JP |
| authorships[2].institutions[0].display_name | Kyushu University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Koichiro Kato |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Center for Molecular Systems, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan, Department of Applied Chemistry, Graduate School of Engineering, Kyushu University, 744 Motooka, Nishi-ku, Fukuoka 819-0395, Japan |
| authorships[3].author.id | https://openalex.org/A5054336320 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-3761-9504 |
| authorships[3].author.display_name | Teruki Honma |
| authorships[3].countries | JP |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210129730 |
| authorships[3].affiliations[0].raw_affiliation_string | RIKEN, Center for Computational Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I4210116810 |
| authorships[3].affiliations[1].raw_affiliation_string | RIKEN, Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[3].institutions[0].id | https://openalex.org/I4210116810 |
| authorships[3].institutions[0].ror | https://ror.org/023rffy11 |
| authorships[3].institutions[0].type | facility |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210110652, https://openalex.org/I4210116810 |
| authorships[3].institutions[0].country_code | JP |
| authorships[3].institutions[0].display_name | RIKEN Center for Biosystems Dynamics Research |
| authorships[3].institutions[1].id | https://openalex.org/I4210129730 |
| authorships[3].institutions[1].ror | https://ror.org/03r519674 |
| authorships[3].institutions[1].type | facility |
| authorships[3].institutions[1].lineage | https://openalex.org/I4210110652, https://openalex.org/I4210129730 |
| authorships[3].institutions[1].country_code | JP |
| authorships[3].institutions[1].display_name | RIKEN Center for Computational Science |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Teruki Honma |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | RIKEN, Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan, RIKEN, Center for Computational Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[4].author.id | https://openalex.org/A5000011261 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-6580-7185 |
| authorships[4].author.display_name | Masateru Ohta |
| authorships[4].countries | JP |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210116810 |
| authorships[4].affiliations[0].raw_affiliation_string | RIKEN, Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I4210129730 |
| authorships[4].affiliations[1].raw_affiliation_string | RIKEN, Center for Computational Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[4].institutions[0].id | https://openalex.org/I4210116810 |
| authorships[4].institutions[0].ror | https://ror.org/023rffy11 |
| authorships[4].institutions[0].type | facility |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210110652, https://openalex.org/I4210116810 |
| authorships[4].institutions[0].country_code | JP |
| authorships[4].institutions[0].display_name | RIKEN Center for Biosystems Dynamics Research |
| authorships[4].institutions[1].id | https://openalex.org/I4210129730 |
| authorships[4].institutions[1].ror | https://ror.org/03r519674 |
| authorships[4].institutions[1].type | facility |
| authorships[4].institutions[1].lineage | https://openalex.org/I4210110652, https://openalex.org/I4210129730 |
| authorships[4].institutions[1].country_code | JP |
| authorships[4].institutions[1].display_name | RIKEN Center for Computational Science |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Masateru Ohta |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | RIKEN, Center for Biosystems Dynamics Research, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan, RIKEN, Center for Computational Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[5].author.id | https://openalex.org/A5069786759 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3199-6931 |
| authorships[5].author.display_name | Mitsunori Ikeguchi |
| authorships[5].countries | JP |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210129730 |
| authorships[5].affiliations[0].raw_affiliation_string | RIKEN, Center for Computational Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan |
| authorships[5].affiliations[1].raw_affiliation_string | Graduate School of Medical Life Science |
| authorships[5].affiliations[2].institution_ids | https://openalex.org/I89630735 |
| authorships[5].affiliations[2].raw_affiliation_string | Yokohama City University |
| authorships[5].institutions[0].id | https://openalex.org/I4210129730 |
| authorships[5].institutions[0].ror | https://ror.org/03r519674 |
| authorships[5].institutions[0].type | facility |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210110652, https://openalex.org/I4210129730 |
| authorships[5].institutions[0].country_code | JP |
| authorships[5].institutions[0].display_name | RIKEN Center for Computational Science |
| authorships[5].institutions[1].id | https://openalex.org/I89630735 |
| authorships[5].institutions[1].ror | https://ror.org/0135d1r83 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I89630735 |
| authorships[5].institutions[1].country_code | JP |
| authorships[5].institutions[1].display_name | Yokohama City University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Mitsunori Ikeguchi |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Graduate School of Medical Life Science, RIKEN, Center for Computational Science, 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan, Yokohama City University |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12199291 |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Quantitative Structure–Activity Relationships for Human Galectin-3 Inhibitors: Insights from Quantum Chemical Interaction Energy Terms |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12387 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9998999834060669 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Galectins and Cancer Biology |
| related_works | https://openalex.org/W1980758437, https://openalex.org/W1970435430, https://openalex.org/W4287510099, https://openalex.org/W4387064608, https://openalex.org/W2014209709, https://openalex.org/W2099982459, https://openalex.org/W1966980303, https://openalex.org/W4226462951, https://openalex.org/W2006933535, https://openalex.org/W2949251425 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | pmh:oai:pubmedcentral.nih.gov:12199291 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2764455111 |
| best_oa_location.source.issn | |
| best_oa_location.source.type | repository |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | PubMed Central |
| best_oa_location.source.host_organization | https://openalex.org/I1299303238 |
| best_oa_location.source.host_organization_name | National Institutes of Health |
| best_oa_location.source.host_organization_lineage | https://openalex.org/I1299303238 |
| best_oa_location.license | cc-by-nc-nd |
| best_oa_location.pdf_url | |
| best_oa_location.version | submittedVersion |
| best_oa_location.raw_type | Text |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc-nd |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | J Chem Inf Model |
| best_oa_location.landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12199291 |
| primary_location.id | doi:10.1021/acs.jcim.5c00592 |
| primary_location.is_oa | False |
| primary_location.source.id | https://openalex.org/S167262187 |
| primary_location.source.issn | 1549-9596, 1549-960X |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 1549-9596 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Journal of Chemical Information and Modeling |
| primary_location.source.host_organization | https://openalex.org/P4310320006 |
| primary_location.source.host_organization_name | American Chemical Society |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320006 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Journal of Chemical Information and Modeling |
| primary_location.landing_page_url | https://doi.org/10.1021/acs.jcim.5c00592 |
| publication_date | 2025-06-10 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W1638424324, https://openalex.org/W2157860503, https://openalex.org/W2035427613, https://openalex.org/W2201301173, https://openalex.org/W3102870960, https://openalex.org/W2017107299, https://openalex.org/W2463944685, https://openalex.org/W2126578659, https://openalex.org/W3161795784, https://openalex.org/W3087132815, https://openalex.org/W2474428864, https://openalex.org/W1966077354, https://openalex.org/W2095148640, https://openalex.org/W1501974651, https://openalex.org/W2118622794, https://openalex.org/W4318825769, https://openalex.org/W2131197116, https://openalex.org/W2316407953, https://openalex.org/W4362661361, https://openalex.org/W3034880338, https://openalex.org/W3043320795, https://openalex.org/W2005087735, https://openalex.org/W2003849838, https://openalex.org/W2617113644, https://openalex.org/W2780261212, https://openalex.org/W2909638144, https://openalex.org/W3144926040, https://openalex.org/W2885134323, https://openalex.org/W3150767033, https://openalex.org/W2024234157, https://openalex.org/W4402272925, https://openalex.org/W4406056388, https://openalex.org/W4406027826, https://openalex.org/W3122608869 |
| referenced_works_count | 34 |
| abstract_inverted_index.a | 4, 194, 251 |
| abstract_inverted_index.21 | 35 |
| abstract_inverted_index.DI | 81, 155 |
| abstract_inverted_index.In | 19, 130 |
| abstract_inverted_index.We | 83 |
| abstract_inverted_index.as | 176, 178 |
| abstract_inverted_index.be | 74 |
| abstract_inverted_index.by | 77 |
| abstract_inverted_index.in | 8, 209 |
| abstract_inverted_index.is | 3 |
| abstract_inverted_index.of | 34, 92, 133, 165, 172, 205, 240 |
| abstract_inverted_index.on | 189 |
| abstract_inverted_index.to | 88, 142, 151, 212, 225 |
| abstract_inverted_index.we | 22, 135, 192 |
| abstract_inverted_index.DI, | 120 |
| abstract_inverted_index.For | 106 |
| abstract_inverted_index.Our | 66 |
| abstract_inverted_index.The | 233 |
| abstract_inverted_index.and | 13, 51, 80, 96, 103, 114, 124, 168, 174, 218, 223, 229, 247 |
| abstract_inverted_index.for | 119, 197, 238, 254 |
| abstract_inverted_index.key | 108 |
| abstract_inverted_index.new | 252 |
| abstract_inverted_index.the | 24, 70, 78, 90, 98, 127, 131, 143, 146, 152, 162, 166, 169, 184, 203, 206, 210, 241 |
| abstract_inverted_index.E184 | 141, 217 |
| abstract_inverted_index.QSAR | 235 |
| abstract_inverted_index.R144 | 123, 173, 222 |
| abstract_inverted_index.R184 | 224 |
| abstract_inverted_index.R186 | 115, 125 |
| abstract_inverted_index.been | 17 |
| abstract_inverted_index.case | 132 |
| abstract_inverted_index.four | 38 |
| abstract_inverted_index.from | 59, 140, 216 |
| abstract_inverted_index.have | 16 |
| abstract_inverted_index.high | 198 |
| abstract_inverted_index.most | 128 |
| abstract_inverted_index.near | 221 |
| abstract_inverted_index.ring | 164 |
| abstract_inverted_index.that | 29, 69, 137, 158 |
| abstract_inverted_index.this | 20 |
| abstract_inverted_index.well | 177 |
| abstract_inverted_index.were | 57, 116, 126 |
| abstract_inverted_index.with | 110, 122, 181 |
| abstract_inverted_index.(DI). | 54 |
| abstract_inverted_index.(ES), | 45 |
| abstract_inverted_index.(EX), | 50 |
| abstract_inverted_index.(FMO) | 64 |
| abstract_inverted_index.Based | 188 |
| abstract_inverted_index.CH-π | 179 |
| abstract_inverted_index.E184, | 113 |
| abstract_inverted_index.Human | 0 |
| abstract_inverted_index.N160, | 112 |
| abstract_inverted_index.R144, | 111 |
| abstract_inverted_index.R186, | 175, 182 |
| abstract_inverted_index.These | 55 |
| abstract_inverted_index.could | 73 |
| abstract_inverted_index.found | 136 |
| abstract_inverted_index.shape | 227 |
| abstract_inverted_index.terms | 56, 87 |
| abstract_inverted_index.these | 86, 190 |
| abstract_inverted_index.using | 37 |
| abstract_inverted_index.while | 118 |
| abstract_inverted_index.(QSAR) | 28 |
| abstract_inverted_index.CT+mix | 79, 147 |
| abstract_inverted_index.allows | 237 |
| abstract_inverted_index.charge | 46, 138, 214 |
| abstract_inverted_index.design | 195 |
| abstract_inverted_index.energy | 42, 204 |
| abstract_inverted_index.study, | 21 |
| abstract_inverted_index.target | 5 |
| abstract_inverted_index.terms. | 82 |
| abstract_inverted_index.terms: | 43 |
| abstract_inverted_index.CT+mix, | 107, 134 |
| abstract_inverted_index.analyze | 89 |
| abstract_inverted_index.between | 100, 161, 243 |
| abstract_inverted_index.binding | 32, 71, 104, 153, 248 |
| abstract_inverted_index.derived | 58 |
| abstract_inverted_index.design. | 256 |
| abstract_inverted_index.energy, | 149 |
| abstract_inverted_index.energy. | 187 |
| abstract_inverted_index.enhance | 226 |
| abstract_inverted_index.further | 84 |
| abstract_inverted_index.orbital | 63 |
| abstract_inverted_index.propose | 193 |
| abstract_inverted_index.protein | 6 |
| abstract_inverted_index.quantum | 39, 244 |
| abstract_inverted_index.residue | 101 |
| abstract_inverted_index.several | 14 |
| abstract_inverted_index.various | 9 |
| abstract_inverted_index.affinity | 33, 72, 199 |
| abstract_inverted_index.analysis | 67, 156 |
| abstract_inverted_index.approach | 236 |
| abstract_inverted_index.aromatic | 163 |
| abstract_inverted_index.chemical | 40, 245 |
| abstract_inverted_index.exchange | 49 |
| abstract_inverted_index.fragment | 61 |
| abstract_inverted_index.lowering | 202 |
| abstract_inverted_index.moieties | 171 |
| abstract_inverted_index.offering | 250 |
| abstract_inverted_index.orbitals | 208 |
| abstract_inverted_index.parallel | 159 |
| abstract_inverted_index.residues | 95 |
| abstract_inverted_index.revealed | 68, 157 |
| abstract_inverted_index.specific | 93 |
| abstract_inverted_index.stacking | 160 |
| abstract_inverted_index.transfer | 47, 139, 215 |
| abstract_inverted_index.(CT+mix), | 48 |
| abstract_inverted_index.FMO-based | 234 |
| abstract_inverted_index.affinity, | 249 |
| abstract_inverted_index.affinity. | 105, 154 |
| abstract_inverted_index.diseases, | 10 |
| abstract_inverted_index.evaluated | 97 |
| abstract_inverted_index.explained | 75 |
| abstract_inverted_index.fibrosis, | 12 |
| abstract_inverted_index.findings, | 191 |
| abstract_inverted_index.guanidine | 170 |
| abstract_inverted_index.guideline | 196 |
| abstract_inverted_index.including | 11 |
| abstract_inverted_index.influence | 30 |
| abstract_inverted_index.inhibitor | 144, 167, 211 |
| abstract_inverted_index.molecular | 62, 255 |
| abstract_inverted_index.primarily | 76 |
| abstract_inverted_index.stabilize | 230 |
| abstract_inverted_index.DI-induced | 185 |
| abstract_inverted_index.decomposed | 85 |
| abstract_inverted_index.dispersion | 52, 231 |
| abstract_inverted_index.facilitate | 213 |
| abstract_inverted_index.galectin-3 | 1 |
| abstract_inverted_index.implicated | 7 |
| abstract_inverted_index.inhibitors | 15, 36 |
| abstract_inverted_index.stabilized | 145, 183 |
| abstract_inverted_index.unoccupied | 207 |
| abstract_inverted_index.correlation | 242 |
| abstract_inverted_index.identified, | 117 |
| abstract_inverted_index.identified. | 18 |
| abstract_inverted_index.inhibitors: | 201 |
| abstract_inverted_index.interaction | 41, 148, 186 |
| abstract_inverted_index.introducing | 219 |
| abstract_inverted_index.perspective | 253 |
| abstract_inverted_index.contributing | 150 |
| abstract_inverted_index.correlations | 99 |
| abstract_inverted_index.interactions | 53, 109, 121, 180, 246 |
| abstract_inverted_index.investigated | 23 |
| abstract_inverted_index.quantitative | 25 |
| abstract_inverted_index.significant. | 129 |
| abstract_inverted_index.substituents | 220 |
| abstract_inverted_index.<i>h</i>Gal-3 | 31, 94, 200 |
| abstract_inverted_index.calculations. | 65 |
| abstract_inverted_index.contributions | 91, 102 |
| abstract_inverted_index.electrostatic | 44 |
| abstract_inverted_index.interactions. | 232 |
| abstract_inverted_index.investigation | 239 |
| abstract_inverted_index.relationships | 27 |
| abstract_inverted_index.high-precision | 60 |
| abstract_inverted_index.(<i>h</i>Gal-3) | 2 |
| abstract_inverted_index.complementarity | 228 |
| abstract_inverted_index.structure-activity | 26 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 6 |
| citation_normalized_percentile.value | 0.81144188 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |